Inconstant apolipoprotein E (ApoE)-like immunoreactivity in amyloid β protein deposits: Relationship with APOE genotype in aging brain and Alzheimer's disease

Acta Neuropathologica

Volumn 92, Issue 2, 1996, Pages 180-185

  Uchihara, Toshiki ^a   Duyckaerts, Charles ^a   Lazarini, Françoise ^a   Mokhtari, Karima ^a   Seilhean, Danielle ^a   Amouyel, Philippe ^b   Hauw, Jean Jacques ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Alzheimer's disease; APOE genotype; Apolipoprotein E; Senile plaque

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; TAU PROTEIN;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTELLECTUAL IMPAIRMENT; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENILE PLAQUE;

AGED; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; FEMALE; GENOTYPE; HUMANS;

EID: 0029977028     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050506     Document Type: Article

References (37)

1. Berr C, Hauw J-J, Delaère P, Duyckaerts C, Amouyel P (1994) Apolipoprotein E allele ε4 is linked to increased deposition of the amyloid β-peptide (Aβ) in cases with or without Alzheimer's disease. Neurosci Lett 178: 221-224
2. Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114: 797-811
3. Braak H, Braak E, Kalus P (1989) Alzheimer's disease: areal and laminar pathology in the occipital isocortex. Acta Neuropathol 77: 494-506
4. Brousseau T, Legrain S, Berr C, Gourlet V, Vidai O, Amouyel P (1994) Confirmation of the ε4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology 44: 342-344
5. Chartier-Harlin M-C, Parfitt M, Legrain S, Perez-Tur J, Brousseau T, Evans A, Berr C, Vidal O, Roques P, Gourlet V, Fruchart J-C, Delacourte A, Rossor M, Amouyel P (1994) Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 3: 569-574
6. Corder EH, Saunders AM, Strittmater WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
7. Delaère P, Duyckaerts C, Brion JP, Poulain V, Hauw J-J (1989) Tau, paired helical filaments and amyloid in the neocortex: a morphometric study of 15 cases with graded intellectual status in aging and senile dementia of Alzheimer type. Acta Neuropathol 77: 645-653
8. Delaère P, Duyckaerts C, Masters C, Beyreuther K, Piette F, Hauw J-J (1990) Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person. Neurosci Lett 116: 87-93
9. Delaère P, Duyckaerts C, He Y, Piette F, Hauw J-J (1991) Subtypes and differential laminar distributions of βA4 depositis in Alzheimer's disease: relationship with the intellectual status of 26 cases. Acta Neuropathol 81: 328-335
10. Delaère P, He Y, Fayet G, Duyckaerts C, Hauw J-J (1993) βA4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians. Neurobiol Aging 14: 191-194
11. Dickson DW, Ivanushkin A, Heitner J, Yen S-H, Davies P (1995) Apolipoprotein E immunoreactivity is increased in amyloid deposits of Alzheimer's disease, but not pathological aging or diffuse Lewy body disease. In: Iqbal K, Mortimer JM, Winblad B, Wisniewski HM (eds) Research advances in Alzheimer's disease and related disorders. Wiley, Chichester, pp 371-383
12. Duyckaerts C, Hauw J-J, Bastenaire F, Piette F, Poulain C, Rainsard V, Javoy-Agid F, Berthaux P (1986) Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol (Berl) 70: 249-256
13. Gearing M, Schneider JA, Robbins RS, Hollister RD, Mori H, Games D, Hyman BT, Mirra SS (1995) Regional variation in the distribution of apolipoprotien E and Aβ in Alzheimer's disease. J Neuropathol Exp Neurol 54: 833-841
14. He Y, Duyckaerts C, Delaère P, Piette F, Hauw J-J (1993) Alzheimer's lesions labelled by anti-ubiquitin antibodies: comparison with other staining techniques. A study of 15 cases with graded intellectual status in ageing and Alzheimer's disease. Neuropathol Appl Neurobiol 19: 364-371
15. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42: 1097-1105
16. Kida E, Golabek AA, Wisniewski T, Wisniewski HE (1994) Regional differences in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease brain. Neurosci Lett 167: 73-76
17. Lamy C, Duyckaerts C, Delaère P, Payan C, Fermanian J, Poulain V, Hauw J-J (1989) Comparison of seven staining methods for senile plaques and neurofibrillary tangles in a prospective series of 15 elderly patients. Neuropathol Appl Neurobiol 15: 563-578
18. Leroy A, Vu-dac N, Koffigan M, Clavey V, Fruchart JC (1988) Characterization of a monoclonal antibody that bind to apolipoprotein E and to lipoprotein of human plasma containing ApoE. Application to ELISA quantification of plasma ApoE. J Immunoassay 9: 309-334
19. Lewis DA, Campbell MJ, Terry RD, Morrison JH (1987) Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci 7: 1799-1808
20. 1-anticymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372: 92-94
21. Maestre G, Ottman R, Stern Y, Gurland B, Chun M, Tang MX, Shelanski M, Tycko B, Mayeux R (1995) Apolipoprotien E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 37: 254-259
22. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630
23. Majocha RE, Benes FM, Reifel JL, Rodenrys AM, Marotta CA (1988) Laminar-specific distribution and infrastructural detail of amyloid in the Alzheimer disease cortex visualized by computer-enhanced imaging of epitopes recognized by monoclonal antibodies. Proc Natl Acad Sci USA 85: 6182-6186
24. Mayeux R, Stem Y, Ottman R, Tatemichi TK, Tang M-X, Maestre G, Ngai C, Tycko B, Ginsberg H (1993) The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol 34: 752-754
25. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Hughes JP, Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 42: 479-486
26. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541: 163-166
27. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697-699
28. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinisto L, Halonen P, Kontula K (1995) Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 333: 1242-1247
29. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11: 575-580
30. Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD, Strittmatter WJ (1994) Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more effciently than apoE3. J Clin Invest 94: 860-869
31. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1994) Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472
32. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90: 9649-9653
33. Schneider JA, Gearing M, Robbins RS, De l'Aune W, Mirra SS (1995) Apolipoprotein E genotype in diverse neurodegenerative disorders. Ann Neurol 38: 131-135
34. Uchihara T, Duyckaerts C, He Y, Kobayashi K, Seilhean D, Amouyel P, Hauw J-J (1995) ApoE immunoreactivity and microglial cells in Alzheimer's disease brain. Neurosci Lett 195: 5-8
35. Wisniewski T, Frangione B (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135: 235-238
36. Wisniewski T, Castano EM, Golabek A, Vogel T, Frangione B (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 145: 1030-1035
37. Yamaguchi H, Ishiguro K, Sugihara S, Nakazato Y, Kawarabayashi T, Sun X, Hirai S (1994) Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer β-amyloid deposition. Acta Neuropathol 88: 413-419